(Q35570242)

8 August 2017

Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections (English)

1 reference

8 August 2017

Sabbaj J

1

1 reference

8 August 2017

Hoagland VL

series ordinal

2

1 reference

8 August 2017

Shih WJ

series ordinal

3

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 March 1985

1 reference

Antimicrobial Agents and Chemotherapy

8 August 2017

1 reference

8 August 2017

27

1 reference

8 August 2017

297-301

1 reference

8 August 2017

3

1 reference

Susceptibility of clinical isolates of Staphylococcus saprophyticus to fifteen commonly used antimicrobial agents

8 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176264

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176264

In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176264

Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176264

In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176264

In vitro antibacterial activity of norfloxacin (MK-0366).

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176264

Antibiotic susceptibility testing by a standardized single disk method

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176264

Urinary Tract Infection Localization in Women

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176264

Identification of site of urinary-tract infections by antibody-coated bacteria assay

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176264

Norfloxacin disposition after sequentially increasing oral doses

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176264

Antibacterial activity of norfloxacin

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176264

Localization of Urinary-Tract Infections by Detection of Antibody-Coated Bacteria in Urine Sediment

26 September 2018

1 reference

12 December 2020

Effect of Trimethoprim-Sulfamethoxazole on the Renal Excretion of Creatinine in Man

1 reference

12 December 2020

Comparison of the antibacterial activity of norfloxacin (MK 0366, AM 715), a new organic acid, with that of other orally absorbed chemotherapeutic agents

1 reference

12 December 2020

Antibody-Coated Bacteria in the Urine and the Site of Urinary-Tract Infection

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.27.3.297

1 reference

release_ipa7ez2uqjb6zeql3pqaedi7bm

8 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ipa7ez2uqjb6zeql3pqaedi7bm

24 November 2022

mapped directly with Wikidata item

PMCID

176264

1 reference

8 August 2017

1 reference